Markets
| Security ▲ | Price | % | Buy | Sell | Target price | Potential |
|---|---|---|---|---|---|---|
| Akebia Therapeutics Inc. |
€1.22
02.05.24 |
0.170% | 8 | 3 | €3.60 | 195.735% |
| Akorn Inc. |
€0.17
08.08.20 |
- | 0 | 0 | - | - |
| Alder Biopharmaceuticals Inc |
€16.60
22.10.19 |
- | 0 | 0 | - | - |
| Aldeyra Therapeutics Inc. |
€3.93
02.05.24 |
7.200% | 2 | 0 | - | - |
| Alexion Pharmaceutical Inc. |
€154.78
20.07.21 |
1.260% | 0 | 0 | - | - |
| Alimera Sciences |
?
27.11.19 |
9.190% | 3 | 0 | €6.90 | 67.577% |
| Alkermes plc |
€22.80
30.04.24 |
-0.870% | 12 | 2 | €34.08 | 49.477% |
| Alnylam Pharmace. |
€140.00
02.05.24 |
5.670% | 36 | 0 | €228.30 | 63.071% |
| Alpine Immune Sciences Inc |
€60.50
02.05.24 |
-1.640% | 0 | 0 | - | - |
| AMAG Pharmaceuticals Inc. |
€11.61
13.11.20 |
2.340% | 0 | 0 | - | - |
| Amarin Corp. ADR |
€0.86
02.05.24 |
-3.490% | 1 | 2 | €0.89 | 4.561% |
| Amgen Inc. |
€259.65
02.05.24 |
0.970% | 21 | 0 | €294.28 | 13.338% |
| Amicus Therapeutics Inc. |
€9.50
25.04.24 |
-3.550% | 3 | 0 | €18.24 | 92.000% |
| Amphastar Pharmaceuticals Inc |
€39.75
02.05.24 |
3.490% | 0 | 0 | - | - |
| AnaptysBio Inc |
€22.80
30.04.24 |
14.570% | 8 | 1 | €46.24 | 102.807% |
| Anavex Life Sciences Corp |
€3.50
02.05.24 |
1.810% | 0 | 2 | - | - |
| Anika Therapeutics |
€24.20
30.04.24 |
-0.820% | 4 | 0 | €26.58 | 9.840% |
| Ani Pharmaceuticals Inc. |
€62.00
30.04.24 |
0.810% | 0 | 0 | - | - |
| Apellis Pharmaceuticals |
€44.27
02.05.24 |
2.720% | 4 | 0 | €70.00 | 58.121% |
| Aphria Inc. |
€12.71
07.08.21 |
- | 0 | 0 | - | - |
| Applied Genetic Technologies Corp. |
€0.37
28.11.22 |
-0.820% | 0 | 0 | - | - |
| Aptevo Therapeutics Inc. |
€0.12
05.03.24 |
-10.290% | 0 | 0 | - | - |
| Aptose Biosciences |
€0.40
05.06.23 |
-1.550% | 0 | 0 | - | - |
| AquaBounty Technologies Inc |
€0.20
20.11.23 |
6.640% | 0 | 0 | - | - |
| Aquinox Pharmaceuticals Inc |
€3.54
13.08.19 |
3.200% | 0 | 0 | - | - |
| Aradigm Corp. New |
€0.097
18.07.19 |
-12.150% | 0 | 0 | - | - |
| Arbutus Biopharma Corp. |
€2.50
02.05.24 |
0.940% | 0 | 0 | - | - |